SAM
ABBV icon

Stewart Asset Management’s AbbVie ABBV Stock Holding History

Stewart Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,450
Closed -$263K – 29
2020
Q1 		$263K Hold
3,450
– – 0.28% 31
2019
Q4 		$305K Buy
+3,450
New +$286K 0.31% 31

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Stewart Asset Management's ABBV Position: Q2 2020 in Review

Stewart Asset Management sold out of AbbVie (ABBV) in Q2 2020, closing a stake of 3,450 shares — an estimated $263K sold.

Stewart Asset Management first reported a position in ABBV in Q4 2019 and held it in 2 quarters. The position peaked at $305K in Q4 2019. 2,411 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

  • Stewart Asset Management reported no remaining AbbVie position as of Q2 2020 after selling out during the quarter.
  • Stewart Asset Management sold 3,450 AbbVie shares in Q2 2020, an estimated $263K.
  • Stewart Asset Management first reported a position in AbbVie in Q4 2019 and held it in 2 quarters.
  • Stewart Asset Management's AbbVie position peaked at $305K in Q4 2019.
  • 2,411 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Stewart Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.